Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Cash from Investing Activities (2017 - 2021)

Cogent Biosciences has reported Cash from Investing Activities over the past 4 years, most recently at -$433000.0 for Q4 2021.

  • Quarterly results put Cash from Investing Activities at -$433000.0 for Q4 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was -$1.6 million (down 119.6% YoY), and the annual figure for FY2025 was -$399.5 million, down 1143.8%.
  • Cash from Investing Activities for Q4 2021 was -$433000.0 at Cogent Biosciences, up from -$1.2 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for COGT hit a ceiling of $15.0 million in Q4 2018 and a floor of -$41.4 million in Q2 2018.
  • Median Cash from Investing Activities over the past 4 years was $4.3 million (2017), compared with a mean of $1.8 million.
  • Peak annual rise in Cash from Investing Activities hit 822.56% in 2018, while the deepest fall reached 1193.58% in 2018.
  • Cogent Biosciences' Cash from Investing Activities stood at $4.9 million in 2017, then soared by 206.12% to $15.0 million in 2018, then crashed by 100.09% to -$13000.0 in 2019, then crashed by 3230.77% to -$433000.0 in 2021.
  • The last three reported values for Cash from Investing Activities were -$433000.0 (Q4 2021), -$1.2 million (Q3 2021), and -$13000.0 (Q4 2019) per Business Quant data.